Spots Global Cancer Trial Database for Real Life Study on Iron Isomaltoside 1000 in the Treatment of ID in CKD, Heart Failure, ObGyn, IBD, Cancer and Elective Surgery (Real-CHOICE).
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Real Life Study on Iron Isomaltoside 1000 in the Treatment of ID in CKD, Heart Failure, ObGyn, IBD, Cancer and Elective Surgery (Real-CHOICE).
Official Title: Iron Isomaltoside 1000 in Patients With Iron Deficiency or Iron Deficiency Anemia: a Multicentric, Prospective, Longitudinal, Observational Study in Switzerland.
Study ID: NCT04318405
Interventions
Study Description
Brief Summary: Real-CHOICE - designed as a prospective, longitudinal, observational, non-interventional study - will investigate the attitude of patients and physicians towards IV (intravenous) iron therapy in general and IIM (iron isomaltoside 1000) treatment particularly before and after IIM treatment in iron deficient patients with or without anemia in the real-world clinical setting after commercial availability of this product in Switzerland.
Detailed Description:
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
21, Basel, , Switzerland
9, Basel, , Switzerland
1, Bern, , Switzerland
15, Biel, , Switzerland
19, Brugg, , Switzerland
18, Gossau, , Switzerland
11, Kreuzlingen, , Switzerland
12, Kreuzlingen, , Switzerland
8, Kreuzlingen, , Switzerland
5, Liestal, , Switzerland
20, Opfikon, , Switzerland
16, Rheinfelden, , Switzerland
13, Sankt Gallen, , Switzerland
7, Sion, , Switzerland
6, Spreitenbach, , Switzerland
17, St. Gallen, , Switzerland
14, Steinach, , Switzerland
10, Wettingen, , Switzerland
3, Wohlen, , Switzerland
2, Zürich, , Switzerland
4, Zürich, , Switzerland
Contact Details
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
